Knowledge Leaders Capital, LLC Bristol Myers Squibb CO Transaction History

Knowledge Leaders Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$65.71 - $74.53 $18,793 - $21,315	-286 Reduced 2.92%	9,503 $658,000
Q4 2022 Feb 07, 2023	SELL	$68.48 - $81.09 $39,239 - $46,464	-573 Reduced 5.53%	9,789 $704,000
Q3 2022 Nov 02, 2022	SELL	$0.13 - $76.84 $74 - $44,259	-576 Reduced 5.27%	10,362 $737,000
Q2 2022 Aug 03, 2022	SELL	$72.62 - $79.98 $83,658 - $92,136	-1,152 Reduced 9.53%	10,938 $842,000
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $62,747 - $73,148	1,170 Added 10.71%	12,090 $754,000
Q3 2021 Nov 04, 2021	BUY	$59.17 - $69.31 $7,692 - $9,010	130 Added 1.2%	10,920 $646,000
Q2 2021 Aug 09, 2021	BUY	$61.91 - $67.42 $8,048 - $8,764	130 Added 1.22%	10,790 $721,000
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $584,381 - $683,199	10,660 New	10,660 $627,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Knowledge Leaders Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Knowledge Leaders Capital, LLC with notifications on news.